Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Are Currently Being Treated With Eculizumab Active Not Recruiting Phase 3 Trials for Eculizumab (DB01257)

IndicationStatusPhase
DBCOND0082768 (Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Are Currently Being Treated With Eculizumab)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs